Dashboard
Manage Tickers

ALKS


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alkermes-announces-initiation-of-vibrance-2-phase-2-study-evaluating-alks-2680-for-treatment-of-narcolepsy-type-2
Alkermes Announces Initiation Of Vibrance-...
08/22/2024 11:01:32

alkami-sees-q3-total-revenue-838m-853m-vs-8478m-est-sees-fy24-total-revenue-3305m-3335m-vs-33167m-est
Alkami Sees Q3 Total Revenue $83.8M-$85.3M...
07/31/2024 21:09:03

cantor-fitzgerald-reiterates-overweight-on-alkermes-maintains-48-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/25/2024 14:16:54

Cantor Fitzgerald analyst Charles Duncan reiterates Alkermes (NASDAQ:ALKS) with a Overweight and maintains $48 price target.

jp-morgan-maintains-neutral-on-alkermes-raises-price-target-to-32
JP Morgan Maintains Neutral on Alkermes, R...
07/25/2024 13:26:26

JP Morgan analyst Jessica Fye maintains Alkermes (NASDAQ:ALKS) with a Neutral and raises the price target from $31 to $32.

baird-maintains-outperform-on-alkermes-raises-price-target-to-38
Baird Maintains Outperform on Alkermes, Ra...
07/25/2024 11:16:22

Baird analyst Joel Beatty maintains Alkermes (NASDAQ:ALKS) with a Outperform and raises the price target from $37 to $38.

hc-wainwright--co-maintains-neutral-on-alkermes-raises-price-target-to-37
HC Wainwright & Co. Maintains Neutral on A...
07/25/2024 10:39:44

HC Wainwright & Co. analyst Douglas Tsao maintains Alkermes (NASDAQ:ALKS) with a Neutral and raises the price target fro...

why-general-dynamics-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why General Dynamics Shares Are Trading Lo...
07/24/2024 17:26:11

att-group-1-automotive-mattel-seagate-and-other-big-stocks-moving-higher-on-wednesday
AT&T, Group 1 Automotive, Mattel, Seagate ...
07/24/2024 14:46:56

alkermes-q2-2024-adj-eps-072-beats-070-estimate-sales-399131m-beat-393348m-estimate
Alkermes Q2 2024 Adj EPS $0.72 Beats $0.70...
07/24/2024 11:01:59

6-analysts-assess-alkermes-what-you-need-to-know
6 Analysts Assess Alkermes: What You Need ...
07/15/2024 21:00:44

jp-morgan-maintains-neutral-on-alkermes-lowers-price-target-to-31
JP Morgan Maintains Neutral on Alkermes, L...
07/15/2024 13:58:53

JP Morgan analyst Jessica Fye maintains Alkermes (NASDAQ:ALKS) with a Neutral and lowers the price target from $32 to $31.

the-analyst-landscape-7-takes-on-alkermes
The Analyst Landscape: 7 Takes On Alkermes
06/17/2024 12:01:26

td-cowen-initiates-coverage-on-alkermes-with-buy-rating-announces-price-target-of-34
TD Cowen Initiates Coverage On Alkermes wi...
06/17/2024 11:09:31

TD Cowen analyst Joseph Thome initiates coverage on Alkermes (NASDAQ:ALKS) with a Buy rating and announces Price Target of $34.

hc-wainwright--co-reiterates-neutral-on-alkermes-maintains-35-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/04/2024 11:39:01

HC Wainwright & Co. analyst Douglas Tsao reiterates Alkermes (NASDAQ:ALKS) with a Neutral and maintains $35 price target.

alkermes-unveils-phase-1b-data-for-narcolepsy-treatment-at-sleep-2024
Alkermes Unveils Phase 1b Data for Narcole...
06/03/2024 11:04:30

 Alkermes plc (NASDAQ:ALKS) today announced new data from the full narcolepsy type 1 (NT1) cohort of a phase 1b, proof-of-conce...

alkermes-to-present-promising-narcolepsy-treatment-data-at-annual-sleep-conference
Alkermes to Present Promising Narcolepsy T...
05/28/2024 11:11:16

Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024 PRNewswire – Late-Breaking Abstracts Containing Data From t...

6-analysts-assess-alkermes-what-you-need-to-know
6 Analysts Assess Alkermes: What You Need ...
05/23/2024 16:00:52

cantor-fitzgerald-maintains-overweight-on-alkermes-raises-price-target-to-48
Cantor Fitzgerald Maintains Overweight on ...
05/23/2024 15:43:59

Cantor Fitzgerald analyst Charles Duncan maintains Alkermes (NASDAQ:ALKS) with a Overweight and raises the price target from...

7-analysts-assess-alkermes-what-you-need-to-know
7 Analysts Assess Alkermes: What You Need ...
05/02/2024 18:00:24

hc-wainwright--co-reiterates-neutral-on-alkermes-maintains-35-price-target
HC Wainwright & Co. Reiterates Neutral on ...
05/02/2024 17:29:57

HC Wainwright & Co. analyst Douglas Tsao reiterates Alkermes (NASDAQ:ALKS) with a Neutral and maintains $35 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION